Abstract
The present invention relates generally to methods and materials based on diaminophenothiazines for use in the treatment of Mild Cognitive Impairment (MCI).
Original language | English |
---|---|
Patent number | US9211294 |
Priority date | 19/06/07 |
Filing date | 17/06/08 |
Publication status | Published - 15 Dec 2015 |